Journal Of Clinical Oncology (jco) Podcast

Should Myeloma Residual Disease Become a Standard Assay for Large Cooperative Groups and Myeloma Referral Centers?

Informações:

Synopsis

Minimal residual disease predicts outcomes in myeloma.